NCT02769312View on ClinicalTrials.gov

Theta-Burst Neuromodulation for PTSD

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

December 19, 2017

Study Completion Date

December 19, 2017

Conditions
Chronic Post-Traumatic Stress Disorder
Interventions
DEVICE

Theta burst stimulation

Theta burst transcranial magnetic stimulation

DEVICE

Sham stimulation

Sham Theta burst transcranial magnetic stimulation

Trial Locations (1)

02908

Providence VA Medical Center, Providence, RI, Providence

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT02769312 - Theta-Burst Neuromodulation for PTSD | Biotech Hunter | Biotech Hunter